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. Recently, microalgae have been exploited for the production of high-value compounds such as lipids (omega-3 fatty acids), enzymes, polymers, toxins, antioxidants, and pigments (carotenoids) 2 .
Thus, algal biotechnology is defined as 'the technology developed using algae (macro or micro) to make or modify bioactive compounds, or products (nutritional supplements, fine chemicals) and renewable fuels for specific use'.
Out of all metabolites, one of the major groups of marine compounds of interest are the omega-3 fatty acids. Omega-3 fatty acids are naturally occurring important polyunsaturated fatty acids (PUFAs) that include mainly alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) with EPA, DPA and DHA being the most well known in the marine world 3 . These PUFAs possess great relevance to the prevention of sudden death from ventricular fibrillation and are essential for brain development of infants 4 . Recent studies have shown that PUFAs mitigate the symptoms of diseases such as
Alzheimer's, chronic intestinal disorder, and some types of cancer 5, 6 . The National Health and Medical Research Council (NHMRC) recommended intake of long chain omega-3 fatty acids (DHA/EPA) in order to lower the risk of chronic diseases is 610 mg/day for men and 430 mg/day for women, and it is currently estimated that Australians are getting about 160 mg of DHA+EPA per day 7 . The current omega-3 fatty acid products are primarily obtained from fish sources such as sardines, salmon, tuna and herring. Although the global demand is growing, fish as a source of PUFA production is a declining resource. Thus, there is current emphasis on discovering microalgal sources for the production of omega-3 fatty acids.
The algae products market is expected to reach US$44. In this regard, we have a collection of thraustochytrids strains (strains isolated from the low-tide regions of Queenscliff and
Barwon heads, Victoria, as shown in Figure 2 ) that produce high levels of DHA and we have shown that these microbes grow well on glucose 11 . An approximate three-fold improvement in carotenoid content in all isolates was achieved when glycerol was used as a carbon source in the production medium 12 . Based on fatty acid profiling, Australian thraustochytrids, in general, had a higher docosahexaenoic acid (DHA) content with DHA at 17-31% of total fatty acid 13, 14 . We have evaluated the efficiency of various solvents, solvent combinations 15 and cell disruption methods for lipid extraction 16 to make the process cost-effective. Co-product extraction from said strains with emphasis upon astaxanthin has been optimised at lab scale 17 . Tween-80 has recently been investigated in a bioreactor with regard to biomass, lipase and lipid productivity in Schizochytrium sp. S31 18 . Another group from Tasmania has also collected Australian thraustochytrids and investigated life cycle assessment for biodiesel production 19 .
Constraints in omega-3 fatty acid production
Industrial production of omega-3 fatty acids usually requires two prerequisites, low cost and high productivity. High productivity can be achieved only with high cell density and high DHA content.
Fermentation in submerged level is of two types, one stage fermentation and fed-batch fermentation or two stage fermentation; the difference in the process lies with the supply of carbon source.
The carbon source needs to be supplied in fed batch fermentation as it decreases the negative effect of substrate inhibition. High cell density can be achieved through fed-batch fermentation. In Focus
Future perspectives
Biotechnological solution: Innovation both at the laboratory and Industry level should be aimed at devising upstream and downstream strategies for cost-effective polyunsaturated and co-product production. New marine microorganisms from varied habitats need to be continuously to be explored in terms of the isolation of new algal strains that have the capacity to accumulate high concentration of omega-3 fatty acid naturally and other valuable products.
Novel marine sources possessing environmental stress should be explored for the isolation of new algal strains.
Various inexpensive carbon sources, such as whey from the dairy industry, processed fruit pulp from the food processing industry (an important resource for recovering nutrients), bread and bakery waste, 20 crude glycerol, 14 oil cake, lignocellulose resource 21 and molasses can be tested for growing novel microalgal strains 22 . Such cost-effective carbon sources may lead to higher or comparative yield to glucose and glycerol, thus decreasing upstream processing costs. Currently, the cost of fermentation of DHA and EPA is significantly higher than obtaining these fatty acids from fish oils.
Thus, controlled fermentation methods are required for costeffective production of omega-3 fatty acids.
Downstream processing: Rupturing of biomass cell walls prior to solvent contact can improve lipid extraction yields. In addition, process optimisation for co-product production during algal fermentation can improve the overall economics of large-scale algal fermentation.
This write-up presents the potential of microalgae to provide the growing population with a secure, sustainable alternative source of health promoting omega-3 fatty acids for use in food and feeds. In Focus
